What is Brainsway Ltd (BWAY) stock price today?

Brainsway Ltd (BWAY) currently trades at $15.88 per share. The stock has a market capitalization of $655.34M and a P/E ratio of 90.94x.

Is BWAY stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Brainsway Ltd has a Smart Value Score of 46/100 (Grade C), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is the BWAY stock price target for 2026?

WallStSmart's 12-month price target for Brainsway Ltd is $6.75.

What is Brainsway Ltd's revenue and earnings?

Brainsway Ltd has trailing twelve-month (TTM) revenue of $52.23M with profit margins of 14.50%. Earnings per share (EPS) is $0.18.

BWAY

Brainsway Ltd

NASDAQ: BWAY · HEALTHCARE · MEDICAL DEVICES

$15.88

-1.37% today

Updated 2026-04-29

Market cap

$655.34M

P/E ratio

90.94

P/S ratio

12.55x

EPS (TTM)

$0.18

Dividend yield

—

52W range

$4 – $17

Volume

0.2M

Market cap

$655.34M

P/E ratio

90.94

P/S ratio

12.55x

EPS (TTM)

$0.18

Dividend yield

—

52W range

$4 – $17

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: C

Sell

Investment rating

9.3

Growth

A+

5.0

Quality

C+

5.5

Profitability

C+

4.0

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$15.33

-3.46%

12-Month target

$6.75

-57.49%

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 27.40% QoQ

Risks

- Negative free cash flow $-2.02M

- P/E 90.94x — expensive valuation

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$27.18M	$31.79M	$41.02M	$52.64M	$52.23M
Net income	$-13.35M	$-4.20M	$2.92M	$7.69M	$2.95M
EPS	—	—	—	—	$0.18
Free cash flow	$-11.70M	$-1.10M	$6.50M	$16.40M	$-2.02M
Profit margin	-49.12%	-13.20%	7.12%	14.62%	14.50%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BWAY	$655.34M	46	9.3	5.5	4.0	5.0	—	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Brainsway Ltd trades at $15.88. representing a P/E of 90.94x trailing earnings. Our Smart Value Score of 46/100 indicates the stock is fair. TTM revenue stands at $52.23M. with profit margins at 14.50%.

Frequently asked questions

What is Brainsway Ltd's stock price?

Brainsway Ltd (BWAY) trades at $15.88.

Is Brainsway Ltd overvalued?

Smart Value Score 46/100 (Grade C, Sell).

What is the price target of Brainsway Ltd (BWAY)?

The analyst target price is $15.33, representing -3.5% downside from the current price of $15.88.

What is the future stock price of BWAY by 2030?

Our revenue-driven model estimates Brainsway Ltd could reach $9.55 by 2030, based on historical CAGR, margin trends, and capped P/E multiples.

What is Brainsway Ltd's revenue?

TTM revenue is $52.23M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio12.55x

ROE11.20%

Beta0.14

50D MA$13.40

200D MA$9.61

Shares out0.04B

Float0.03B

Short ratio—

Avg volume0.2M

Performance

1 week-2.99%

1 month+16.94%

3 months-32.08%

YTD-16.51%

1 year—

3 years—

5 years—

Compare

BWAY vs LLY →BWAY vs JNJ →BWAY vs ABBV →Stock screener →